Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications

W Danysz, CG Parsons - Pharmacological reviews, 1998 - ASPET
Since the finding by Johnson and Ascher (1987) demonstrating that glycine enhances
electrophysiological responses mediated by N-methyl-D-aspartate (NMDA) b

The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease.

R Cacabelos, M Takeda… - International journal of …, 1999 - search.ebscohost.com
THE GLUTAMATERGIC SYSTEM AND NEURODEGENERATION IN DEMENTIA: PREVENTIVE
STRATEGIES IN ALZHEIMER'S DISEASE Page 1 rNTCRNATIONAL JOURNAL OF GERIATRIC …

Wistar rats show episodic-like memory for unique experiences

E Kart-Teke, MADS Silva, JP Huston, E Dere - Neurobiology of learning and …, 2006 - Elsevier
Human episodic memory refers to the recollection of an unique past experience in terms of
its details, its locale, and temporal occurrence. Episodic memory, even in principle, has been …

Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation

FL Assini, M Duzzioni, RN Takahashi - Behavioural brain research, 2009 - Elsevier
Object location task (OLT) has been used as a model of hippocampal-dependent memory.
Despite this application, there is neither a consistent pharmacological validation of NMDA …

NMDA receptors and fear extinction: implications for cognitive behavioral therapy

M Davis - Dialogues in clinical neuroscience, 2011 - Taylor & Francis
Principaimente mediante esiudios que empiean el miedo condicionado pavloviano se ha
encontrado que la extinción del miedo condicionado es mediada por receptores de N-metil …

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

MD Black - Psychopharmacology, 2005 - Springer
Abstract Background Positive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) modulators enhance glutamate transmission via the AMPA receptor by altering the …

NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease

CH Lin, YJ Huang, CJ Lin, HY Lane… - Current pharmaceutical …, 2014 - ingentaconnect.com
The prevalence of Alzheimer's disease (AD) in the elderly is growing rapidly worldwide, and
the deteriorating clinical course of AD places a heavy burden on both the patients and their …

Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions

M Jansen, G Dannhardt - European journal of medicinal chemistry, 2003 - Elsevier
For decades neuroreceptor research has focused on the development of NMDA glycine-site
antagonists, after Johnson and Ascher found out in 1987 about the co-agonistic character of …

Memory impairment in temporal lobe epilepsy: the role of entorhinal lesions

R Schwarcz, MP Witter - Epilepsy research, 2002 - Elsevier
Temporal lobe epilepsy (TLE) patients are frequently afflicted with deficits in spatial and
other forms of declarative memory. This impairment is likely associated with the medial …

Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice

Z Hliňák, I Krejčı́ - Behavioural brain research, 1998 - Elsevier
Amnesic properties of scopolamine, a muscarinic receptor antagonist, and MK-801, a non-
competitive N-methyl-d-aspartate (NMDA) receptor antagonist, were evaluated in mice by …